What is EXOZ's cash & equivalents?

EXOZ (EXOZ) reported cash & equivalents of $1.44M in Q1 2026.

How has EXOZ's cash & equivalents changed year-over-year?

EXOZ's cash & equivalents decreased by 83.0% year-over-year, from $8.51M to $1.44M.

What is the long-term trend for EXOZ's cash & equivalents?

Over 3 years (2022 to 2025), EXOZ's cash & equivalents has grown at a 75.9% compound annual growth rate (CAGR), from $558.57K to $3.04M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

EXOZ EXOZ Cash & Equivalents

Cash & Equivalents at other companies

GevoGEVO

$78.9M+20.9%

Ginkgo BioworksDNA

$188.67M-46.9%

Nature's Sunshine ProductsNATR

$87.58M+1.3%

UpexiUPXI

$3.48M+1,412%

West Pharmaceutical ServicesWST

$521.4M+29.0%

Archer Daniels MidlandADM

$6.11B+50.7%

Other financials

Income statement

See full

Revenue$17.5K—

Operating income-$2.4M-22.4%

Net income-$2.4M-27.7%

EPS (diluted)-$0.28-27.3%

Balance sheet

See full

Total debt$1.2M-8.8%

Total equity$1.5M-82.8%

Total assets$4.0M-65.1%

Cash flow

See full

Operating cash flow-$1.5M-34.5%

CapEx$57.6K+85.5%

Free cash flow-$1.6M-35.8%

Valuation

See full

Market cap$76.8M-5.6%

Enterprise value$76.57M+1.0%

P/S1,096.1×—

Profitability

See full

Operating margin-14,489.6%—

Net margin-2,909.1%—

FCF margin-10,117.8%—

Returns & leverage

See full

Return on equity-185.8%—

Debt / equity0.8×+0.6×

Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EXOZ's cash & equivalents?: EXOZ (EXOZ) reported cash & equivalents of $1.44M in Q1 2026.
How has EXOZ's cash & equivalents changed year-over-year?: EXOZ's cash & equivalents decreased by 83.0% year-over-year, from $8.51M to $1.44M.
What is the long-term trend for EXOZ's cash & equivalents?: Over 3 years (2022 to 2025), EXOZ's cash & equivalents has grown at a 75.9% compound annual growth rate (CAGR), from $558.57K to $3.04M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.